These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 6789358)
1. Reserpine and alpha-methyldopa in the treatment of tardive dyskinesia. Huang CC; Wang RI; Hasegawa A; Alverno L Psychopharmacology (Berl); 1981; 73(4):359-62. PubMed ID: 6789358 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of reserpine and alpha-methyldopa in the treatment of tardive dyskinesia. Huang CC; Wang RI; Hasegawa A; Alverno L Psychopharmacol Bull; 1980 Jul; 16(3):41-3. PubMed ID: 7403399 [No Abstract] [Full Text] [Related]
3. [Pharmacogenic tardive dyskinesias and their management]. Böszörményi Z Psychiatr Neurol Med Psychol Beih; 1975; 20-21():95-9. PubMed ID: 829644 [TBL] [Abstract][Full Text] [Related]
4. [A double-blind study of the effect of L-dopa in psychotic patients with tardive dyskinesia]. Karniol IG; Giampietro AC; Moura DS; Vilela WA; Oliveira MA; Zuardi AW Acta Psiquiatr Psicol Am Lat; 1983 Dec; 29(4):261-6. PubMed ID: 6369888 [TBL] [Abstract][Full Text] [Related]
5. A therapeutic approach to tardive dyskinesia. Fahn S J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):19-24. PubMed ID: 2858474 [TBL] [Abstract][Full Text] [Related]
6. Vitamin E in the treatment of tardive dyskinesia. Elkashef AM; Ruskin PE; Bacher N; Barrett D Am J Psychiatry; 1990 Apr; 147(4):505-6. PubMed ID: 1969247 [TBL] [Abstract][Full Text] [Related]
7. Long term treatment of tardive dyskinesia. Jus A; Jus K; Fontaine P J Clin Psychiatry; 1979 Feb; 40(2):72-7. PubMed ID: 33156 [TBL] [Abstract][Full Text] [Related]